Correction: 18F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis

• Sébastien Heyer,
• Maïa Simon,
• Matthieu Doyen,
• Ali Mortada,
• Véronique Roch,
• Elodie Jeanbert,
• Nathalie Thilly,
• Catherine Malaplate,
• Anna Kearney-Schwartz,
• Thérèse Jonveaux,
• Aurélie Bannay,
• Antoine Verger

Affiliations

Sébastien Heyer

Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy

Maïa Simon

Department of Methodology, Promotion and Investigation, Université de Lorraine, CHRU-Nancy

Matthieu Doyen

Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy

Ali Mortada

Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy

Véronique Roch

Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy

Elodie Jeanbert

Department of Methodology, Promotion and Investigation, Université de Lorraine, CHRU-Nancy

Nathalie Thilly

Department of Methodology, Promotion and Investigation, Université de Lorraine, CHRU-Nancy

Catherine Malaplate

Department of Biochemistry, Université de Lorraine, CHRU-Nancy

Anna Kearney-Schwartz

Department of Geriatrics, Université de Lorraine, CHRU-Nancy

Thérèse Jonveaux

CMRR, University Hospital Nancy

Aurélie Bannay

Medical Assessment and Information Department, Université de Lorraine, CHRU-Nancy

Antoine Verger

Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy